IRIS
CASTELLI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 200
NA - Nord America 160
AS - Asia 35
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 160
SE - Svezia 107
IT - Italia 50
CN - Cina 24
RU - Federazione Russa 23
SG - Singapore 9
FI - Finlandia 8
DE - Germania 6
IE - Irlanda 3
IN - India 2
RO - Romania 2
AU - Australia 1
EU - Europa 1
FR - Francia 1
ZA - Sudafrica 1
Totale 398
Salva come PNG Salva come JPEG
Città #
Ashburn 45
Milan 41
Princeton 24
Lawrence 23
Shanghai 22
Moscow 13
New York 10
Helsinki 8
Los Angeles 4
Singapore 4
Bologna 3
Dublin 3
Frankfurt Am Main 3
Ancona 2
Boardman 2
Como 2
Pune 2
Bloemfontein 1
Borås 1
Guangzhou 1
Lansing 1
Melbourne 1
Riverside 1
Rockville 1
Rome 1
Seattle 1
Segrate 1
Totale 221
Salva come PNG Salva come JPEG
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 37
A Biologically-validated HCV E1E2 Heterodimer Structural Model 25
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 22
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 22
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 22
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 20
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 20
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 19
Viral Respiratory Pathogens and Lung Injury 19
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 18
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 18
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 17
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 16
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 16
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 16
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 14
Role and potential therapeutic use of antibodies against herpetic infections 14
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 14
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets 14
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 14
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 13
HCV E2 core structures and mAbs: something is still missing 13
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 11
Salts drive controllable multilayered upright assembly of amyloid-like peptides at mica/water interface 11
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 8
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 5
null 1
Totale 452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 5 0 0 0 0 0 1 0 0 0 0 1
2020/20219 2 0 0 1 0 0 1 0 0 5 0 0
2021/202230 2 1 7 4 0 0 0 2 2 3 3 6
2022/2023186 57 45 25 1 1 27 10 11 7 0 2 0
2023/2024161 0 9 26 30 14 33 4 20 4 9 1 11
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 452